Iradimed (IRMD) Net Cash Flow (2013 - 2026)

Iradimed (IRMD) has 14 years of Net Cash Flow data on file, last reported at $5.2 million in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $5.2 million, up 374.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 16.13% YoY), and the FY2025 annual result was -$1.1 million, down 143.5% from the prior year.
• Net Cash Flow grew to $5.2 million in Q1 2026 per IRMD's latest filing, from -$5.4 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $5.2 million in Q1 2026 and troughed at -$15.2 million in Q1 2023.
• A 5-year average of -$330961.9 and a median of $2.4 million in 2022 frame the typical range for Net Cash Flow.
• The sharpest annual moves came in 2022 and 2026: Net Cash Flow slumped 1676.35% in 2022, then jumped 374.04% in 2026.
• A 5-year view of Net Cash Flow shows it stood at $2.4 million in 2022, then advanced by 27.37% to $3.0 million in 2023, then tumbled by 83.03% to $512147.0 in 2024, then tumbled by 1147.99% to -$5.4 million in 2025, then jumped by 197.16% to $5.2 million in 2026.
• Business Quant data shows IRMD's Net Cash Flow at $5.2 million in Q1 2026, -$5.4 million in Q4 2025, and $3.5 million in Q3 2025.